Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of recombinant human interleukin-1 receptor antagonist in adults with moderate-to-severe active rheumatoid arthritis
CTR20190711Phase 3Active
- Sponsor
- 3S Guojian Pharmaceutical
- Start
- Aug 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of anakinra in rheumatoid arthritis (RA), sponsored by 3S Guojian Pharmaceutical. Started Aug 2019; status: active.
02
Drugs
anakinra
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20190711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190711.